Compositions and methods of use of ORF 554 from beta hemolytic streptococcal strains
View Patent ↗The present invention relates to compositions and methods of use comprising peptidyl-prolyl isomerase (PPI) polypeptides of group C and G streptococci and polynucleotides encoding same. The invention also relates to immunogenic compositions comprising the PPI polypeptides and polynucleotides, as well as antibodies and antibody fragments that bind the PPI polypeptides. In addition, the invention relates to methods of inducing an immune response in a subject against beta hemolytic streptococci using the immunogenic compositions, as well as conferring passive immunity by administering a therapeutic antibody or antibody fragment.
1. An isolated polypeptide that comprises an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO: 11.
2. The isolated polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 11.
3. An immunogenic composition comprising an isolated polypeptide that comprises:
a) an amino acid sequence that is 90% identical to the amino acid sequence of SEQ ID NO: 11; or
b) the amino acid sequence of SEQ ID NO: 11.
4. A kit comprising an isolated polypeptide that comprises an amino acid sequence that is 90% identical to the amino acid sequence of SEQ ID NO: 11.